Biological basis for chemo-radiotherapy interactions
- 1 January 2002
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 38 (2) , 223-230
- https://doi.org/10.1016/s0959-8049(01)00360-4
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Poly(ADP-ribose) polymerase, a major determinant of early cell response to ionizing radiationInternational Journal of Radiation Biology, 2000
- Radiation-induced DNA double-strand breaks and the radiosensitivity of human cells: A closer lookBiochimie, 1997
- HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease.Proceedings of the National Academy of Sciences, 1994
- Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung CancerNew England Journal of Medicine, 1992
- Cisplatin and radiation: Interaction probabilities and therapeutic possibilitiesInternational Journal of Radiation Oncology*Biology*Physics, 1990
- The search for therapeutic gain in the combination of radiotherapy and chemotherapyRadiotherapy and Oncology, 1988
- In situ localization of DNA topoisomerase II, a major polypeptide component of the Drosophila nuclear matrix fraction.Proceedings of the National Academy of Sciences, 1985
- Localization of topoisomerase II in mitotic chromosomes.The Journal of cell biology, 1985
- Terminology in the description of drug-radiation interactionsInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivityInternational Journal of Radiation Oncology*Biology*Physics, 1979